Stocks›Healthcare
WatchAlert

Symbiotec Pharmalab Limited

SYMBIOTEC · NSE · Healthcare · As of 8 Nov 2026
₹1,597.90
+₹84.30 (+5.57%)(1D)
₹934.20Since listing range₹1,628.00
Market Cap
—
P/E (Sector)
83.7 (32.3)
P/B Ratio
—
Dividend Yield
—
ROE
9.6%
Debt / Equity
0.34
Anvest Score
52/100
  • Valuation
    44
  • Quality
    42
  • Growth
    44
  • Health
    85
  • Momentum
    —
Loading company profile…

Fundamentals

P/E Ratio (TTM)
83.66
Sector median P/E
32.29
P/B Ratio
—
Sector median P/B
4.4
EPS (TTM)
₹19.1
ROE
9.56%
ROCE
11.62%
Profit Margin
12.6%
Debt/Equity
0.34
Loading technical indicators…
Loading financial statement…
Loading shareholding…
Loading filings…

Symbiotec Pharmalab Limited FAQs

3 topics
Expand
What does the Symbiotec Pharmalab Limited (SYMBIOTEC) stock page cover?
Symbiotec Pharmalab Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.
What are the current headline metrics for SYMBIOTEC?
Symbiotec Pharmalab Limited is currently shown with a delayed price near ₹1,597.9, P/E 83.66, and ROE 9.56%.
Does the SYMBIOTEC page provide investment advice?
No. The SYMBIOTEC page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.
Keep exploring

Related insights